DrugPatentWatch Database Preview

Bionpharma Inc Company Profile

« Back to Dashboard

What is the competitive landscape for BIONPHARMA INC, and what generic alternatives to BIONPHARMA INC drugs are available?

BIONPHARMA INC has twenty-four approved drugs.

There are five US patents protecting BIONPHARMA INC drugs.

There are nineteen patent family members on BIONPHARMA INC drugs in seventeen countries and twenty-four supplementary protection certificates in eleven countries.

Summary for Bionpharma Inc

International Patents:	19
US Patents:	5
Tradenames:	24
Ingredients:	21
NDAs:	24
Drug Master File Entries:	2
Patent Litigation for Bionpharma Inc:	See patent lawsuits for Bionpharma Inc

Drugs and US Patents for Bionpharma Inc

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bionpharma Inc	ETHOSUXIMIDE	ethosuximide	CAPSULE;ORAL	040430-001	Oct 28, 2002	AB	RX	No	No
Bionpharma Inc	METHYLPHENIDATE HYDROCHLORIDE	methylphenidate hydrochloride	TABLET;ORAL	209753-001	Mar 2, 2018	AB	RX	No	No
Bionpharma Inc	TETRABENAZINE	tetrabenazine	TABLET;ORAL	208826-001	Dec 18, 2017	AB	RX	No	No
Bionpharma Inc	BEXAROTENE	bexarotene	CAPSULE;ORAL	203174-001	Aug 12, 2014	AB	RX	No	No
Bionpharma Inc	NAPROXEN SODIUM	naproxen sodium	CAPSULE;ORAL	021920-001	Feb 17, 2006		OTC	Yes	Yes	9,693,979		Y
Bionpharma Inc	PARICALCITOL	paricalcitol	CAPSULE;ORAL	202539-002	Mar 27, 2014	AB	RX	No	No
Bionpharma Inc	CLOBAZAM	clobazam	TABLET;ORAL	208825-002	Oct 22, 2018	AB	RX	No	No

Expired US Patents for Bionpharma Inc

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bionpharma Inc	MIDOL LIQUID GELS	ibuprofen	CAPSULE;ORAL	021472-001	Oct 18, 2002	6,251,426

International Patents for Bionpharma Inc Drugs

Country	Document Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2006096580
Cyprus	1118321
Japan	2003508434
China	102940887
Spain	2606767
Hungary	E030784
Mexico	2007011039

Supplementary Protection Certificates for Bionpharma Inc Drugs

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
00085	Netherlands		PRODUCT NAME: LEVOCETIRIZINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER LEVOCETIRINE DIHYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 26770 20011009; FIRST REGISTRATION: DE 49903.00.00 AND 49904.00.00 20010103
00054	Netherlands		PRODUCT NAME: BEXAROTENE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AAN- VAARDBAAR ZOUT OF IN DE VORM VAN EEN ESTER MET EEN HYDROXYVER- BINDING MET DE FORMULE R9OH, WAARIN R9 EEN; NAT. REGISTRATION NO/DATE: EU/1/01/178/001 20010329; FIRST REGISTRATION: EU/1/01/178/001 20010329
2011005	Lithuania		PRODUCT NAME: NAPROXENUM + ESOMEPRAZOLUM; REGISTRATION NO/DATE: LT/1/10/2302/001-LT/1/10/2302/012 20110126
C/GB11/015	United Kingdom		PRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE; REGISTERED: UK PL 17901/0263-0001 20101105
1411900/01	Switzerland		PRODUCT NAME: ESOMEPRAZOL + NAPROXEN; REGISTRATION NO/DATE: SWISSMEDIC 61330 06.05.2011
C/GB03/018	United Kingdom		PRODUCT NAME: DUTASTERIDE, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SOLVATE.; REGISTERED: SE 17871 20020719; SE 17872 20020719; UK PL 19494/0005 20030117; UK PL 19494/0006 20030117
C/GB11/013	United Kingdom		PRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE; REGISTERED: UK PL 17901/0263-0001 20101105

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Bionpharma Inc